Medicare Enrolled

Dr. Kowriah Amirthalingam, M.D.

Pulmonary Disease · Youngstown, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4694 BELMONT AVE STE 2, Youngstown, OH 44505
3304804080
In practice since 2005 (20 years)
NPI: 1699769968 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amirthalingam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amirthalingam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amirthalingam

Dr. Kowriah Amirthalingam is a pulmonary disease specialist in Youngstown, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Amirthalingam performed 485 Medicare services across 441 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amirthalingam received a total of $3,309 from 15 pharmaceutical and/or device companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amirthalingam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 485 Medicare services $3,309 industry payments

Medicare Practice Summary

Medicare Utilization ↗
485
Medicare services
Bottom 43% in OH for pulmonary disease
441
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
108 $95 $191
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
77 $7 $15
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
70 $9 $20
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
61 $8 $21
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
57 $109 $247
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
29 $29 $47
New patient office visit, complex (60-74 min) 28 $137 $326
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
21 $283 $360
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
20 $6 $24
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $63 $134
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,309
Total received (2018-2024)
Avg $552/year across 6 years
Top 38% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
99
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,309 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,364
2023
$787
2022
$343
2021
$542
2020
$228
2018
$45

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$427
Regeneron Healthcare Solutions, Inc.
$306
GlaxoSmithKline, LLC.
$246
United Therapeutics Corporation
$114
Inspire Medical Systems, Inc.
$102
GENZYME CORPORATION
$82
Gilead Sciences, Inc.
$53
Amgen Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$15
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$993
GlaxoSmithKline, LLC.
$536
Regeneron Healthcare Solutions, Inc.
$347
GENZYME CORPORATION
$232
JAZZ PHARMACEUTICALS INC.
$227
Jazz Pharmaceuticals Inc.
$169
United Therapeutics Corporation
$138
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
HARMONY BIOSCIENCES LLC
$114
Actelion Pharmaceuticals US, Inc.
$108
Inspire Medical Systems, Inc.
$102
Harmony Biosciences LLC
$65
Gilead Sciences, Inc.
$53
Advanced Respiratory, Inc
$51
Amgen Inc.
$45
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO ELLIPTA · AREXVY · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · Epclusa · FARXIGA · FASENRA · INSPIRE · Life 2000 Ventilation System · NUCALA · OFEV · SPIRIVA RESPIMAT · SUNOSI · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Wakix · XYREM · XYWAV · Xyrem
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Youngstown?
Compare pulmonary diseases in the Youngstown area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
15
Per 100K population
6.6
County median income
$55,576
Nearest hospital
BELMONT PINES HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Amirthalingam is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Amirthalingam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Amirthalingam performed 108 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amirthalingam receive payments from pharmaceutical companies?
Yes. Dr. Amirthalingam received a total of $3,309 from 15 companies across 99 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amirthalingam's costs compare to other pulmonary diseases in Youngstown?
Dr. Amirthalingam's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amirthalingam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →